Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.730
-0.010 (-0.57%)
Mar 6, 2026, 4:00 PM EST - Market closed
Aethlon Medical Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | - | - | - | 0.57 | 0.29 | 0.66 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 95.21% | -55.37% | 1.37% | Upgrade
|
| Gross Profit | - | - | - | 0.57 | 0.29 | 0.66 | Upgrade
|
| Selling, General & Admin | 7.33 | 9.34 | 12.64 | 12.47 | 10.72 | 8.55 | Upgrade
|
| Operating Expenses | 7.33 | 9.34 | 12.64 | 12.47 | 10.72 | 8.55 | Upgrade
|
| Operating Income | -7.33 | -9.34 | -12.64 | -11.9 | -10.42 | -7.89 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 0.19 | 0.3 | 0.45 | 0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -4.33 | -4.33 | -0.02 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -11.49 | -13.39 | -12.21 | -11.89 | -10.42 | -7.89 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.14 | - | - | Upgrade
|
| Other Unusual Items | -0.03 | - | - | - | - | - | Upgrade
|
| Pretax Income | -11.52 | -13.39 | -12.21 | -12.03 | -10.42 | -7.89 | Upgrade
|
| Earnings From Continuing Operations | -11.52 | -13.39 | -12.21 | -12.03 | -10.42 | -7.89 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0 | 0 | Upgrade
|
| Net Income | -11.52 | -13.39 | -12.21 | -12.03 | -10.42 | -7.89 | Upgrade
|
| Net Income to Common | -11.52 | -13.39 | -12.21 | -12.03 | -10.42 | -7.89 | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 240.14% | 396.93% | 22.35% | 39.17% | 22.05% | - | Upgrade
|
| EPS (Basic) | -28.51 | -85.77 | -388.67 | -468.60 | -564.68 | -521.81 | Upgrade
|
| EPS (Diluted) | -28.51 | -85.77 | -388.67 | -468.60 | -564.68 | -521.81 | Upgrade
|
| Free Cash Flow | -6.92 | -7.65 | -10.38 | -11.45 | -10.12 | -6.82 | Upgrade
|
| Free Cash Flow Per Share | -17.12 | -48.98 | -330.49 | -445.94 | -548.43 | -451.56 | Upgrade
|
| Gross Margin | - | - | - | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | - | -2072.05% | -3542.53% | -1197.31% | Upgrade
|
| Profit Margin | - | - | - | -2094.89% | -3540.90% | -1196.58% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -1993.62% | -3439.01% | -1035.47% | Upgrade
|
| EBITDA | -7.01 | -9 | -12.28 | -11.66 | -10.3 | -7.85 | Upgrade
|
| D&A For EBITDA | 0.33 | 0.34 | 0.36 | 0.24 | 0.12 | 0.04 | Upgrade
|
| EBIT | -7.33 | -9.34 | -12.64 | -11.9 | -10.42 | -7.89 | Upgrade
|
| Revenue as Reported | - | - | - | 0.57 | 0.29 | 0.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.